These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 22123951)

  • 1. Antitumor activity from antigen-specific CD8 T cells generated in vivo from genetically engineered human hematopoietic stem cells.
    Vatakis DN; Koya RC; Nixon CC; Wei L; Kim SG; Avancena P; Bristol G; Baltimore D; Kohn DB; Ribas A; Radu CG; Galic Z; Zack JA
    Proc Natl Acad Sci U S A; 2011 Dec; 108(51):E1408-16. PubMed ID: 22123951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using the BLT humanized mouse as a stem cell based gene therapy tumor model.
    Vatakis DN; Bristol GC; Kim SG; Levin B; Liu W; Radu CG; Kitchen SG; Zack JA
    J Vis Exp; 2012 Dec; (70):e4181. PubMed ID: 23271478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human melanoma immunotherapy using tumor antigen-specific T cells generated in humanized mice.
    Hu Z; Xia J; Fan W; Wargo J; Yang YG
    Oncotarget; 2016 Feb; 7(6):6448-59. PubMed ID: 26824989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introduction of exogenous T-cell receptors into human hematopoietic progenitors results in exclusion of endogenous T-cell receptor expression.
    Vatakis DN; Arumugam B; Kim SG; Bristol G; Yang O; Zack JA
    Mol Ther; 2013 May; 21(5):1055-63. PubMed ID: 23481324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained transgene expression by human cord blood derived CD34+ cells transduced with simian immunodeficiency virus agmTYO1-based vectors carrying the human coagulation factor VIII gene in NOD/SCID mice.
    Kikuchi J; Mimuro J; Ogata K; Tabata T; Ueda Y; Ishiwata A; Kimura K; Takano K; Madoiwa S; Mizukami H; Hanazono Y; Kume A; Hasegawa M; Ozawa K; Sakata Y
    J Gene Med; 2004 Oct; 6(10):1049-60. PubMed ID: 15386735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term in vivo provision of antigen-specific T cell immunity by programming hematopoietic stem cells.
    Yang L; Baltimore D
    Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4518-23. PubMed ID: 15758071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential use of T cell receptor genes to modify hematopoietic stem cells for the gene therapy of cancer.
    Clay TM; Custer MC; Spiess PJ; Nishimura MI
    Pathol Oncol Res; 1999; 5(1):3-15. PubMed ID: 10079371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of WT1-specific human CD8+ T cells from human HSCs in HLA class I Tg NOD/SCID/IL2rgKO mice.
    Najima Y; Tomizawa-Murasawa M; Saito Y; Watanabe T; Ono R; Ochi T; Suzuki N; Fujiwara H; Ohara O; Shultz LD; Yasukawa M; Ishikawa F
    Blood; 2016 Feb; 127(6):722-34. PubMed ID: 26702062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human allogeneic stem cell maintenance and differentiation in a long-term multilineage SCID-hu graft.
    Fraser CC; Kaneshima H; Hansteen G; Kilpatrick M; Hoffman R; Chen BP
    Blood; 1995 Sep; 86(5):1680-93. PubMed ID: 7655000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4-directed peptide vaccination augments an antitumor response, but efficacy is limited by the number of CD8+ T cell precursors.
    Hanson HL; Kang SS; Norian LA; Matsui K; O'Mara LA; Allen PM
    J Immunol; 2004 Apr; 172(7):4215-24. PubMed ID: 15034034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active form of Notch imposes T cell fate in human progenitor cells.
    De Smedt M; Reynvoet K; Kerre T; Taghon T; Verhasselt B; Vandekerckhove B; Leclercq G; Plum J
    J Immunol; 2002 Sep; 169(6):3021-9. PubMed ID: 12218117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allelic exclusion and peripheral reconstitution by TCR transgenic T cells arising from transduced human hematopoietic stem/progenitor cells.
    Giannoni F; Hardee CL; Wherley J; Gschweng E; Senadheera S; Kaufman ML; Chan R; Bahner I; Gersuk V; Wang X; Gjertson D; Baltimore D; Witte ON; Economou JS; Ribas A; Kohn DB
    Mol Ther; 2013 May; 21(5):1044-54. PubMed ID: 23380815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic potential of a tumor-specific, MHC-unrestricted T-cell receptor expressed on effector cells of the innate and the adaptive immune system through bone marrow transduction and immune reconstitution.
    Alajez NM; Schmielau J; Alter MD; Cascio M; Finn OJ
    Blood; 2005 Jun; 105(12):4583-9. PubMed ID: 15746083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell differentiation/maturation of CD34+ stem cells from HIV-seropositive hemophiliacs in cultured thymic epithelial fragments.
    Ruiz M; Roodman ST; Bouhasin JD; Knutsen AP
    Stem Cells; 1996 Jan; 14(1):132-45. PubMed ID: 8820959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rare population of tumor antigen-specific CD4
    Matsuzaki J; Tsuji T; Chodon T; Ryan C; Koya RC; Odunsi K
    J Immunother Cancer; 2019 Jan; 7(1):7. PubMed ID: 30626427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular evidence of lentiviral vector-mediated gene transfer into human self-renewing, multi-potent, long-term NOD/SCID repopulating hematopoietic cells.
    Ailles L; Schmidt M; Santoni de Sio FR; Glimm H; Cavalieri S; Bruno S; Piacibello W; Von Kalle C; Naldini L
    Mol Ther; 2002 Nov; 6(5):615-26. PubMed ID: 12409260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extrathymic generation of tumor-specific T cells from genetically engineered human hematopoietic stem cells via Notch signaling.
    Zhao Y; Parkhurst MR; Zheng Z; Cohen CJ; Riley JP; Gattinoni L; Restifo NP; Rosenberg SA; Morgan RA
    Cancer Res; 2007 Mar; 67(6):2425-9. PubMed ID: 17363559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive detection of tumor-infiltrating T cells by PET reporter imaging.
    McCracken MN; Vatakis DN; Dixit D; McLaughlin J; Zack JA; Witte ON
    J Clin Invest; 2015 May; 125(5):1815-26. PubMed ID: 25822024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human CD34+ fetal liver stem cells differentiate to T cells in a mouse thymic microenvironment.
    Plum J; De Smedt M; Defresne MP; Leclercq G; Vandekerckhove B
    Blood; 1994 Sep; 84(5):1587-93. PubMed ID: 7520780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel CD8+ T cell-based vaccine stimulates Gp120-specific CTL responses leading to therapeutic and long-term immunity in transgenic HLA-A2 mice.
    Nanjundappa RH; Wang R; Xie Y; Umeshappa CS; Xiang J
    Vaccine; 2012 May; 30(24):3519-25. PubMed ID: 22484292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.